1. "2024"
Formats
  1. Journal Article (2329)
  2. Meeting Abstract (1694)
  3. Review (589)
  4. Editorial (305)
  5. Book Section (98)
  6. Correspondence (92)
  7. Guidelines (90)
  8. Research Letter (89)
  9. Miscellaneous (55)
  10. Conference Paper (33)
  11. Book Whole (3)
Groups
  1. Department of Medicine (2141)
  2. Solid Tumor Oncology Division (1382)
  3. Sloan Kettering Institute Postdocs (1038)
  4. Surgery (984)
  5. Graduate Medical Education (883)
  6. GSK Faculty (868)

More Groups

People
  1. Eileen O'Reilly (75)
  2. Saad Usmani (75)
  3. Edward Christopher Dee (70)
  4. Nadeem Abu-Rustum (70)
  5. Alice Wei (69)
  6. T Peter Kingham (68)

More People

Years
  1. 2024 (5377)
Publications
  1. Journal of Clinical Oncology (521)
  2. International Journal of Radiation Oncology, Biology, Physics (186)
  3. Blood (161)
  4. Annals of Oncology (147)
  5. Annals of Surgical Oncology (131)
  6. Laboratory Investigation (91)

More Publications

Publishers
  1. Elsevier Inc. (784)
  2. American Society of Clinical Oncology (580)
  3. Nature Publishing Group (384)
  4. Springer (357)
  5. Oxford University Press (347)
  6. Elsevier Science, Inc. (256)

More Publishers

Results (5377)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The combination of patient-specific tumor and HPV sequencing to enable high-sensitivity detection of ctDNA in patients with HPV-associated oropharyngeal carcinoma
    Meeting Abstract

    Diplas, B.; Brown, D. N.; Pei, X.; Chen, L.; Graybill, C.; Korn, W. M.; Westheimer, E.; Novaj, A.; Humm, J.; Shukla-Dave, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Associations of dietary fructose with survival of patients (pts) with metastatic cancer of the urothelium (UC) and renal cell carcinoma (RCC) on immune checkpoint blockade (ICB)
    Meeting Abstract

    Badri, A.; Guercio, B. J.; Ratna, N.; Gavrilov, D.; Metzker, N.; Duzgol, C.; Teo, M. Y.; Regazzi, A. M.; Supplice, L.; Funt, S. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Racial and ethnic differences in patient-reported provider communication among patients with cancer
    Meeting Abstract

    Swami, N.; Patel, T. A.; Dee, E. C. C.; Thom, B.; Chino, F.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A single-center retrospective analysis of allergies and survival outcomes in pancreatic adenocarcinoma
    Meeting Abstract

    Li, P. C. W.; Saldia, A.; Olson, S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Effects of plant-based diet (PBD) and exercise therapy (Ex) on weight and body composition in patients with primary hormone receptor (HR) positive breast cancer: A phase 2 randomized controlled trial
    Meeting Abstract

    Iyengar, N. M.; Salehi, E.; Lavery, J. A.; Chan, O.; Lehman, S.; Michalski, M. G.; Fickera, G.; Carlson, A.; Harrison, J.; Underwood, W. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • The acceptability of hospital-at-home for persons living with cancer and their caregivers
    Meeting Abstract

    Lage, D. E.; Hoque, A.; White, C.; Baser, R. E.; Panageas, K.; Schrag, D.; Grudzen, C.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real world incidence, prevention, and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with venetoclax in the inpatient and outpatient settings
    Meeting Abstract

    Valtis, Y.; Nemirovsky, D.; Derkach, A.; Roeker, L. E.; Sharan, S.; Kabel, C.; Ortiz, R.; Geyer, M. B.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma
    Meeting Abstract

    Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Das, J. P.; Lezcano, C.; Nair, S.; Lochrin, S. E.; Chen, M. F.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Standardizing radiologic reporting of response to improve the patient experience: Comparing response categories of RECIST 1.1 and a novel, real-world, standardized, oncologic response lexicon derived from clinical radiology reports
    Meeting Abstract

    Chen, M. F.; Ma, W.; Caravella, B. A.; Harada, G.; Gangai, N.; Grimaldi, G.; Waksmundzki, A.; Trevenen, W.; Kohlasch, K.; Reynolds, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save